January 30, 2025 11:10 GMT
HEALTHCARE: Thermo Fisher (TMO: A3 pos/ A-/A-): Q4 & FY24
HEALTHCARE
4th Quarter showing some improved momentum
- Q4 revenue $11.4bn +4.7% yoy; ahead of 11.29bn consensus
- Full year Revenue $42.88bn flat yoy
- Will provide 2025 guidance in conference call at 08:30 EST
- Operating Income $2,016 showed a margin improvement of 70bps to 17.7%
- The company has previously guided for $75bn of capital deployment, of which 60-75% will be M&A, over next 5yrs.
56 words